PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction.
Edwards AG, Rees ML, Gioscia RA, Zachman DK, Lynch JM, Browder JC, Chicco AJ, Moore RL. PKC-permitted elevation of sarcolemmal KATP concentration may explain female-specific resistance to myocardial infarction. J Physiol. 2009 Dec 01; 587(Pt 23):5723-37.